• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, May 20, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home News

EssilorLuxottica, Meta announce long-term partnership on smart glasses

by Staff Writer
September 24, 2024
in Business, International, News
Reading Time: 2 mins read
A A
Smart glasses are seen as the next big advance in wearable technology. Image: EssilorLuxottica.

Smart glasses are seen as the next big advance in wearable technology. Image: EssilorLuxottica.

Share on FacebookShare on Twitter

EssilorLuxottica has entered into a long-term agreement with Meta Platforms to develop “multi-generational smart eyewear products” into the next decade.

The two companies have been collaborating since 2019, producing two generations of Ray-Ban branded smart glasses.

In a statement, EssilorLuxottica said those glasses broke the barriers to adoption and redefined the potential for consumer wearables.

“By striking the ultimate balance between form and function, using EssilorLuxottica’s know-how in the industry and its global network of retail and wholesale locations,  together with Meta’s advancements in technology, Ray-Ban Meta glasses have garnered excitement and widespread adoption.”

The glasses are now in Australia, as well as the US, Canada, the UK, and many European countries including Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Norway, Spain and Sweden.

“Over the past six decades, EssilorLuxottica has led the transformation and modernisation of the eyewear and eyecare industry, positioning among the world’s leading innovators,” said Mr Francesco Milleri, chairman and CEO EssilorLuxottica.

“We invest hundreds of millions every year in R&D to create products that improve the quality of life for billions of people, and impact how they see the world and each other.

Mr Mark Zuckerberg, founder and CEO of Meta, was proud of the work with EssilorLuxottica so far and excited about the long-term future of the relationship.

“We have the opportunity to turn “glasses into the next major technology platform, and make it fashionable in the process”.

The latest generation of Ray-Ban Meta glasses, introduced by EssilorLuxottica and Meta in 2023, have advanced technology built into Ray-Ban’s iconic frames. They give consumers the ability to make phone calls, capture and share photos and videos, listen to music, and livestream content.

In other news from EssilorLuxottica, the company revealed plans to move into a new global headquarters in Paris, expected to open late 2027.

Located at Place Valhubert, in the heart of the lively Austerlitz district -Paris 13e-, boasting a tech start-up and global digital company scene, the new headquarters will bring together in a single building about 2,000 people, regrouping teams from departments currently spread across different locations in the Grand Paris area.

More reading

Smart glasses from EssilorLuxottica and Meta win prestigious design competitions

Ray-Ban smart glasses bridge technology-fashion divide

Making smart glasses more than a gimmick

Related Posts

The company has developed an “age-related myopia management lens solution”. Image: ZEISS.

New ZEISS MyoCare myopia lens data

by Staff Writer
May 20, 2025

The latest one-year and two-year results from the ongoing multi-centre trials of ZEISS MyoCare lenses consistently demonstrate the slowing of...

Vision 20/20 Australia board chair Christopher Pyne is standing down following heart surgery in March. Image: Vision 20/20 Australia.

Vision 2020 Australia board chair Christopher Pyne stepping down

by Staff Writer
May 19, 2025

Vision 2020 Australia board chair Mr Christopher Pyne is stepping down from the board in November after five years’ service....

A survey circulated by the World Economic Forum suggests the Asia Pacific region will be hit hard by vision loss. Image: Tomasz/stock.adobe.com.

APAC shouldering burden of vision loss, says World Economic Forum

by Staff Writer
May 19, 2025

A major health survey commissioned by Roche suggests the Asia-Pacific region, including Australia, will shoulder a disproportionate burden from vision...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited